Aerobic vs Resistance Exercise in Post-menopausal Women With Type 1 Diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age45-75
SponsorUniversity of Alberta
About this trial
Participants will be asked to wear a continuous glucose monitor for at least three days on three separate occasions. One testing session will be a no-exercise resting control session (90 minutes). One will be a moderate aerobic exercise session (30 minutes of exercise, 60 minutes of recovery), and the third will be a moderate weight-lifting session (\~30 minutes of exercise, 60 minutes of recovery).The investigators will measure changes in blood glucose during exercise by drawing blood during and after exercise. Post-exercise glucose trends will be examined using continuous glucose monitoring.
Eligibility criteria
Qualifiers
type 1 diabetes, diagnosed for at least one year
post-menopause (at least one year since last menstrual period), or have had a hysterectomy and bilateral salpingo oophorectomy
able to perform aerobic and resistance exercise
able to visit the lab in Edmonton, Alberta (University of Alberta)
Disqualifiers
HbA1c > 9.9 %
frequent and unpredictable hypoglycemia
change in insulin management strategy within the last 2 months
blood pressure > 140 / 95
Trial design
Treatments tested in this trial
- Aerobic Exercise
- Resistance Exercise
- No exercise
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Alberta
Lead sponsor
Women and Children's Health Research Institute, Canada
Collaborator
Source ClinicalTrials.gov